Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

HAHAE
Showing 8 of 31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in HAEMONETICS CORP MASS

Yes. BNP Paribas Financial Markets holds 9,611 shares of HAE (Haemonetics Corp Mass), worth $720,825, as of its Q2 2026 13F filing. It reduced the position by 34,424 shares (-78.2%) from Q1 2026. BNP Paribas Financial Markets has held HAE in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$720,825

Current Shares

9,611

Total Value Change

-$641,536

Total Shares Change

-7,338

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
9,611
-78.2%
$720,8250.0%$75.00
0
2026-Q1
Decreased
44,035
-35.3%
$2.5M0.0%$56.36
0
2025-Q4
Increased
68,010
+315.9%
$5.5M0.0%$80.15
44
2025-Q3
Increased
16,352
+2.0%
$796,9960.0%$48.74
25
2025-Q2
Decreased
16,031
-11.9%
$1.2M0.0%$74.61
0
2025-Q1
Decreased
18,200
-45.2%
$1.2M0.0%$63.55
0
2024-Q4
Increased
33,209
+95.9%
$2.6M0.0%$78.08
42
2024-Q3
Increased
16,949
+174.5%
$1.4M0.0%$80.38
41

Other major holders of HAE: WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used